C-PAP/PHEN/PROST/ATROP 150/5/5 recalled over sterility concerns
- Recall date
- July 26, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Pharmacy Plus, Inc. dba Vital Care Compounder recalls C-PAP/PHEN/PROST/ATROP 150/5/5 (Papaverine 150mg/Phentolamine 5mg/Prostaglandin 50mcg/Atropine 0.04mg injection), Rx, 1…
- Recall number
- D-1545-2016
- FDA classification
- Class II
- Brand / firm
- Pharmacy Plus, Inc. dba Vital Care Compounder
- Sold / distributed
- MS
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
C-PAP/PHEN/PROST/ATROP 150/5/5 (Papaverine 150mg/Phentolamine 5mg/Prostaglandin 50mcg/Atropine 0.04mg injection), Rx, 10 ml vials contain 5.8 ml solution, Vital Care COMPOUNDER, Hattiesburg, MS 39402
Get recall alerts
Free email alert whenever Pharmacy Plus, Inc. dba Vital Care Compounder has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Pharmacy Plus, Inc. dba Vital Care Compounder